| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |